We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+15.61%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.74B
AUM Growth
+$743M
Cap. Flow
+$207M
Cap. Flow %
4.37%
Top 10 Hldgs %
17.46%
Holding
1,440
New
165
Increased
569
Reduced
526
Closed
100

Top Buys

Rank Stock Value
1
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$20.3M
2
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$16.8M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$16.2M
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$15.9M
5
CWB icon
State Street SPDR Bloomberg Convertible Securities ETF
CWB
+$15.5M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$9.67M
2
LOW icon
Lowe's Companies
LOW
+$6.73M
3
ALB icon
Albemarle
ALB
+$5.55M
4
VEEV icon
Veeva Systems
VEEV
+$5.27M
5
CHWY icon
Chewy
CHWY
+$5.11M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 11.15%
3 Financials 10.55%
4 Consumer Discretionary 9.84%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORMP icon
1326
Oramed Pharmaceuticals
ORMP
$176M
$51K ﹤0.01%
+12,000
New +$39K
OPK icon
1327
Opko Health
OPK
$1.04B
$49K ﹤0.01%
12,500
-23,500
-65% -$98.1K
PVLA
1328
Palvella Therapeutics
PVLA
$2.24B
$48K ﹤0.01%
238
-62
-21% -$12.9K
WTER
1329
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$45K ﹤0.01%
2,947
– –
AMPE
1330
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$40K ﹤0.01%
+84
New +$27.6K
BMY.RT
1331
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$30K ﹤0.01%
43,424
+630
+1% +$1.34K
WATT icon
1332
Energous
WATT
$104M
$29K ﹤0.01%
27
– –
ATHX
1333
DELISTED
Athersys, Inc. Common Stock
ATHX
$18K ﹤0.01%
400
– –
WRN
1334
Western Copper and Gold
WRN
$551M
$12K ﹤0.01%
10,000
– –
SENS icon
1335
Senseonics Holdings Inc
SENS
$414M
$9K ﹤0.01%
500
– –
DMK
1336
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
171
– –
DSKEW
1337
DELISTED
Daseke, Inc. Warrant
DSKEW
$6K ﹤0.01%
+34,200
New +$8.24K
GSAT icon
1338
Globalstar
GSAT
$10.8B
$3K ﹤0.01%
667
– –
ADAP
1339
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-36,837
Closed -$294K
AES icon
1340
AES
AES
$10.5B
– –
-32,440
Closed -$587K
OPTU
1341
Optimum Communications Inc
OPTU
$319M
– –
-18,333
Closed -$477K
AVDL
1342
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-27,904
Closed -$141K
AVNT icon
1343
Avient
AVNT
$4.19B
– –
-44,375
Closed -$1.17M
BAC.PRL icon
1344
Bank of America Series L
BAC.PRL
$4B
– –
-234
Closed -$348K
BANX
1345
ArrowMark Financial
BANX
$197M
– –
-13,520
Closed -$262K
BCX icon
1346
BlackRock Resources & Commodities Strategy Trust
BCX
$965M
– –
-45,003
Closed -$268K
BEKE icon
1347
KE Holdings
BEKE
$18.7B
– –
-9,173
Closed -$562K
BLNK icon
1348
Blink Charging
BLNK
$86.1M
– –
-34,320
Closed -$354K
BSET icon
1349
Bassett Furniture
BSET
$171M
– –
-21,693
Closed -$297K
BTAL icon
1350
AGF US Market Neutral Anti-Beta Fund
BTAL
$301M
– –
-19,474
Closed -$459K
52 53
54
55 56

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Oppenheimer & Co held 1,440 positions worth $4.74B, up 19% from $4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co deployed $207M of net new capital in Q4 2020, opening 165 new positions and adding to 569 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $9.67M trimmed.

  • Oppenheimer & Co's largest Q4 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.
  • Oppenheimer & Co added most to Vanguard Intermediate-Term Bond ETF in Q4 2020, an estimated $20.3M increase.
  • Oppenheimer & Co's biggest Q4 2020 reduction was ProShares Short S&P500, cutting an estimated $9.67M.
  • Oppenheimer & Co fully exited PagerDuty in Q4 2020, selling an estimated $2.96M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.74B portfolio in Q4 2020.
  • Oppenheimer & Co opened 165 new positions and closed 100 in Q4 2020.
  • Oppenheimer & Co's portfolio value rose 19% quarter-over-quarter to $4.74B.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.